BEUDAMED
    FDA Adverse Event Injury Summary report: N

    STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR

    MDR report key: 5667937 · Received May 19, 2016

    Report

    Report Number
    3007566237-2016-02056
    Event Type
    Injury
    Date Received
    May 19, 2016
    Date of Event
    January 1, 2016
    Report Date
    May 19, 2016
    Manufacturer
    MEDTRONIC NEUROMODULATION
    Product Code
    MHY
    PMA / PMN Number
    P960009
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    UK
    Reporter Occupation
    PHYSICIAN

    Narratives

    Additional Manufacturer Narrative · 1

    IT WAS NOT POSSIBLE TO ASCERTAIN SPECIFIC DEVICE INFORMATION FROM THE ARTICLE OR TO MATCH THE EVENTS REPORTED WITH PREVIOUSLY REPORTED EVENTS. THE DEVICE WAS USED FOR AN OFF LABEL INDICATION.

    Additional Manufacturer Narrative · 1

    IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

    Description of Event or Problem · 1

    AKRAM, H., MILLER, S., LAGRATA, S., HYAM, J., JAHANSHAHI, M., HARIZ, M., MATHARU, M., ZRINZO, L. VENTRAL TEGMENTAL AREA DEEP BRAIN STIMULATION FOR REFRACTORY CHRONIC CLUSTER HEADACHE. NEUROLOGY. 2016. 86:1-7. SUMMARY: TO PRESENT OUTCOMES IN A COHORT OF MEDICALLY INTRACTABLE CHRONIC CLUSTER HEADACHE (CCH) PATIENTS TREATED WITH VENTRAL TEGMENTAL AREA (VTA) DEEP BRAIN STIMULATION (DBS). REPORTED EVENT FOR PATIENT 4: A (B)(6) MALE PATIENT WHO HAD RECEIVED AN OCCIPITAL NERVE STIMULATOR (ONS) IMPLANTED TO TREAT THEIR CHRONIC CLUSTER HEADACHE (CCH) FAILED TO RESPOND ADEQUATELY WITH LIMITED OR SHORT LASTING EFFECT. AS A RESULT THEY HAD THEIR ONS DEVICE EXPLANTED IN EXCHANGE FOR A DEEP BRAIN STIMULATION (DBS) SYSTEM, WHICH LED TO A SIGNIFICANT IMPROVEMENT IN THEIR SYMPTOMS.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    322283 STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR MHY MEDTRONIC NEUROMODULATION NEU_INS_STIMULATOR UNKNOWN

    Patients

    Seq Age Sex Outcome Treatment
    1 49 YR Required Intervention